» Articles » PMID: 23897544

Development of Systemic Lupus Erythematosus in a Male-to-female Transsexual: the Role of Sex Hormones Revisited

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2013 Jul 31
PMID 23897544
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) predominantly affects women of childbearing age. The infrequency of SLE in men and disease onset in prepubertal or postmenopausal women suggests a role of estrogen in the predisposition to the disease. Patients with hypergonadotrophic hypogonadism are prone to the development of SLE, and the use of exogenous estrogens in women increases the relative risk of SLE onset and disease flares. These observations provide indirect evidence for an opposite role of estrogens and androgens in the pathogenesis of SLE. We report on a male-to-female transsexual who developed SLE 20 years after sex-reassignment surgery and prolonged estrogen therapy. The role of sex hormones in SLE is revisited.

Citing Articles

Independent effects of testosterone, estradiol, and sex chromosomes on gene expression in immune cells of trans- and cisgender individuals.

Harris R, Whitfield T, Blanton L, Skaletsky H, Blumen K, Hyland P bioRxiv. 2024; .

PMID: 39416170 PMC: 11482753. DOI: 10.1101/2024.10.08.617275.


Dermatological care of gender-diverse patients in Australia.

Wong R, Harrington J, Stevenson A Australas J Dermatol. 2024; 65(8):601-609.

PMID: 39115047 PMC: 11629140. DOI: 10.1111/ajd.14360.


Reduction of IFN-I responses by plasmacytoid dendritic cells in a longitudinal trans men cohort.

Grunhagel B, Borggrewe M, Hagen S, Ziegler S, Henseling F, Glau L iScience. 2023; 26(11):108209.

PMID: 37953956 PMC: 10637924. DOI: 10.1016/j.isci.2023.108209.


Sex hormone-dependent and -independent regulation of serum BAFF and TNF in cohorts of transgender and cisgender men and women.

Tsatsanis C, Elenkov A, Leijonhufvud I, Vaporidi K, Tivesten A, Giwercman A Endocr Connect. 2023; 12(3).

PMID: 36607156 PMC: 9986405. DOI: 10.1530/EC-22-0456.


Potential immunological effects of gender-affirming hormone therapy in transgender people - an unexplored area of research.

White A, Lin A, Bickendorf X, Cavve B, Moore J, Siafarikas A Ther Adv Endocrinol Metab. 2022; 13:20420188221139612.

PMID: 36533187 PMC: 9747891. DOI: 10.1177/20420188221139612.